anti-CD28 monoclonal antibody

This page covers all anti-CD28 monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD28.

Targets

CD28

Phase 3 pipeline (1)

• AML Y mg · Celltrion · Oncology
  AML Y mg is an anti-CD28 monoclonal antibody that inhibits T-cell activation.

Patent intelligence

• cd28 monoclonal antibody patent landscape — aggregated cliff calendar, attackable patents, originator estates